Global Live Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Live Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Live Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Live Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Live Vaccines Segment by Type

2.2.1 Monovalent Live Vaccines

2.2.2 Multivalent Live Vaccines

2.3 Live Vaccines Sales by Type

2.3.1 Global Live Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Live Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Live Vaccines Sale Price by Type (2017-2022)

2.4 Live Vaccines Segment by Application

2.4.1 Adults

2.4.2 Children

2.5 Live Vaccines Sales by Application

2.5.1 Global Live Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Live Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Live Vaccines Sale Price by Application (2017-2022)

3 Global Live Vaccines by Company

3.1 Global Live Vaccines Breakdown Data by Company

3.1.1 Global Live Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Live Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Live Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Live Vaccines Revenue by Company (2020-2022)

3.2.2 Global Live Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Live Vaccines Sale Price by Company

3.4 Key Manufacturers Live Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Live Vaccines Product Location Distribution

3.4.2 Players Live Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Live Vaccines by Geographic Region

4.1 World Historic Live Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Live Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Live Vaccines Annual Revenue by Geographic Region

4.2 World Historic Live Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Live Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Live Vaccines Annual Revenue by Country/Region

4.3 Americas Live Vaccines Sales Growth

4.4 APAC Live Vaccines Sales Growth

4.5 Europe Live Vaccines Sales Growth

4.6 Middle East & Africa Live Vaccines Sales Growth

5 Americas

5.1 Americas Live Vaccines Sales by Country

5.1.1 Americas Live Vaccines Sales by Country (2017-2022)

5.1.2 Americas Live Vaccines Revenue by Country (2017-2022)

5.2 Americas Live Vaccines Sales by Type

5.3 Americas Live Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Live Vaccines Sales by Region

6.1.1 APAC Live Vaccines Sales by Region (2017-2022)

6.1.2 APAC Live Vaccines Revenue by Region (2017-2022)

6.2 APAC Live Vaccines Sales by Type

6.3 APAC Live Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Live Vaccines by Country

7.1.1 Europe Live Vaccines Sales by Country (2017-2022)

7.1.2 Europe Live Vaccines Revenue by Country (2017-2022)

7.2 Europe Live Vaccines Sales by Type

7.3 Europe Live Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Live Vaccines by Country

8.1.1 Middle East & Africa Live Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Live Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Live Vaccines Sales by Type

8.3 Middle East & Africa Live Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Live Vaccines

10.3 Manufacturing Process Analysis of Live Vaccines

10.4 Industry Chain Structure of Live Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Live Vaccines Distributors

11.3 Live Vaccines Customer

12 World Forecast Review for Live Vaccines by Geographic Region

12.1 Global Live Vaccines Market Size Forecast by Region

12.1.1 Global Live Vaccines Forecast by Region (2023-2028)

12.1.2 Global Live Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Live Vaccines Forecast by Type

12.7 Global Live Vaccines Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Live Vaccines Product Offered

13.1.3 Merck Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline Live Vaccines Product Offered

13.2.3 GlaxoSmithKline Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Live Vaccines Product Offered

13.3.3 Pfizer Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Novartis

13.4.1 Novartis Company Information

13.4.2 Novartis Live Vaccines Product Offered

13.4.3 Novartis Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis Main Business Overview

13.4.5 Novartis Latest Developments

13.5 Astellas Pharma

13.5.1 Astellas Pharma Company Information

13.5.2 Astellas Pharma Live Vaccines Product Offered

13.5.3 Astellas Pharma Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Astellas Pharma Main Business Overview

13.5.5 Astellas Pharma Latest Developments

13.6 Emergent BioSolutions

13.6.1 Emergent BioSolutions Company Information

13.6.2 Emergent BioSolutions Live Vaccines Product Offered

13.6.3 Emergent BioSolutions Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Emergent BioSolutions Main Business Overview

13.6.5 Emergent BioSolutions Latest Developments

13.7 AstraZeneca

13.7.1 AstraZeneca Company Information

13.7.2 AstraZeneca Live Vaccines Product Offered

13.7.3 AstraZeneca Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 AstraZeneca Main Business Overview

13.7.5 AstraZeneca Latest Developments

14 Research Findings and Conclusion

Table 1. Live Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Live Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Monovalent Live Vaccines

Table 4. Major Players of Multivalent Live Vaccines

Table 5. Global Live Vaccines Sales by Type (2017-2022) & (K Doses)

Table 6. Global Live Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Live Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Live Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Live Vaccines Sale Price by Type (2017-2022) & (USD/Dose)

Table 10. Global Live Vaccines Sales by Application (2017-2022) & (K Doses)

Table 11. Global Live Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Live Vaccines Revenue by Application (2017-2022)

Table 13. Global Live Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Live Vaccines Sale Price by Application (2017-2022) & (USD/Dose)

Table 15. Global Live Vaccines Sales by Company (2020-2022) & (K Doses)

Table 16. Global Live Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Live Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Live Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Live Vaccines Sale Price by Company (2020-2022) & (USD/Dose)

Table 20. Key Manufacturers Live Vaccines Producing Area Distribution and Sales Area

Table 21. Players Live Vaccines Products Offered

Table 22. Live Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Live Vaccines Sales by Geographic Region (2017-2022) & (K Doses)

Table 26. Global Live Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Live Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Live Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Live Vaccines Sales by Country/Region (2017-2022) & (K Doses)

Table 30. Global Live Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Live Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Live Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Live Vaccines Sales by Country (2017-2022) & (K Doses)

Table 34. Americas Live Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Live Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Live Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Live Vaccines Sales by Type (2017-2022) & (K Doses)

Table 38. Americas Live Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Live Vaccines Sales by Application (2017-2022) & (K Doses)

Table 40. Americas Live Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Live Vaccines Sales by Region (2017-2022) & (K Doses)

Table 42. APAC Live Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Live Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Live Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Live Vaccines Sales by Type (2017-2022) & (K Doses)

Table 46. APAC Live Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Live Vaccines Sales by Application (2017-2022) & (K Doses)

Table 48. APAC Live Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Live Vaccines Sales by Country (2017-2022) & (K Doses)

Table 50. Europe Live Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Live Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Live Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Live Vaccines Sales by Type (2017-2022) & (K Doses)

Table 54. Europe Live Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Live Vaccines Sales by Application (2017-2022) & (K Doses)

Table 56. Europe Live Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Live Vaccines Sales by Country (2017-2022) & (K Doses)

Table 58. Middle East & Africa Live Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Live Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Live Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Live Vaccines Sales by Type (2017-2022) & (K Doses)

Table 62. Middle East & Africa Live Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Live Vaccines Sales by Application (2017-2022) & (K Doses)

Table 64. Middle East & Africa Live Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Live Vaccines

Table 66. Key Market Challenges & Risks of Live Vaccines

Table 67. Key Industry Trends of Live Vaccines

Table 68. Live Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Live Vaccines Distributors List

Table 71. Live Vaccines Customer List

Table 72. Global Live Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 73. Global Live Vaccines Sales Market Forecast by Region

Table 74. Global Live Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Live Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Live Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 77. Americas Live Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Live Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 79. APAC Live Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Live Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 81. Europe Live Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Live Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Middle East & Africa Live Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Live Vaccines Sales Forecast by Type (2023-2028) & (K Doses)

Table 85. Global Live Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Live Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Live Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Live Vaccines Sales Forecast by Application (2023-2028) & (K Doses)

Table 89. Global Live Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Live Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Live Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Live Vaccines Product Offered

Table 94. Merck Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. GlaxoSmithKline Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. GlaxoSmithKline Live Vaccines Product Offered

Table 99. GlaxoSmithKline Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 100. GlaxoSmithKline Main Business

Table 101. GlaxoSmithKline Latest Developments

Table 102. Pfizer Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Pfizer Live Vaccines Product Offered

Table 104. Pfizer Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 105. Pfizer Main Business

Table 106. Pfizer Latest Developments

Table 107. Novartis Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Novartis Live Vaccines Product Offered

Table 109. Novartis Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 110. Novartis Main Business

Table 111. Novartis Latest Developments

Table 112. Astellas Pharma Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Astellas Pharma Live Vaccines Product Offered

Table 114. Astellas Pharma Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 115. Astellas Pharma Main Business

Table 116. Astellas Pharma Latest Developments

Table 117. Emergent BioSolutions Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. Emergent BioSolutions Live Vaccines Product Offered

Table 119. Emergent BioSolutions Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 120. Emergent BioSolutions Main Business

Table 121. Emergent BioSolutions Latest Developments

Table 122. AstraZeneca Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. AstraZeneca Live Vaccines Product Offered

Table 124. AstraZeneca Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 125. AstraZeneca Main Business

Table 126. AstraZeneca Latest Developments

List of Figures

Figure 1. Picture of Live Vaccines

Figure 2. Live Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Live Vaccines Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Live Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Live Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Monovalent Live Vaccines

Figure 10. Product Picture of Multivalent Live Vaccines

Figure 11. Global Live Vaccines Sales Market Share by Type in 2021

Figure 12. Global Live Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Live Vaccines Consumed in Adults

Figure 14. Global Live Vaccines Market: Adults (2017-2022) & (K Doses)

Figure 15. Live Vaccines Consumed in Children

Figure 16. Global Live Vaccines Market: Children (2017-2022) & (K Doses)

Figure 17. Global Live Vaccines Sales Market Share by Application (2017-2022)

Figure 18. Global Live Vaccines Revenue Market Share by Application in 2021

Figure 19. Live Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Live Vaccines Revenue Market Share by Company in 2021

Figure 21. Global Live Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Live Vaccines Revenue Market Share by Geographic Region in 2021

Figure 23. Global Live Vaccines Sales Market Share by Region (2017-2022)

Figure 24. Global Live Vaccines Revenue Market Share by Country/Region in 2021

Figure 25. Americas Live Vaccines Sales 2017-2022 (K Doses)

Figure 26. Americas Live Vaccines Revenue 2017-2022 ($ Millions)

Figure 27. APAC Live Vaccines Sales 2017-2022 (K Doses)

Figure 28. APAC Live Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. Europe Live Vaccines Sales 2017-2022 (K Doses)

Figure 30. Europe Live Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Live Vaccines Sales 2017-2022 (K Doses)

Figure 32. Middle East & Africa Live Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Americas Live Vaccines Sales Market Share by Country in 2021

Figure 34. Americas Live Vaccines Revenue Market Share by Country in 2021

Figure 35. United States Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Live Vaccines Sales Market Share by Region in 2021

Figure 40. APAC Live Vaccines Revenue Market Share by Regions in 2021

Figure 41. China Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Live Vaccines Sales Market Share by Country in 2021

Figure 48. Europe Live Vaccines Revenue Market Share by Country in 2021

Figure 49. Germany Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Live Vaccines Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Live Vaccines Revenue Market Share by Country in 2021

Figure 56. Egypt Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Live Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Live Vaccines in 2021

Figure 62. Manufacturing Process Analysis of Live Vaccines

Figure 63. Industry Chain Structure of Live Vaccines

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles